CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.02
Tradestie Score
51
Market Cap
$149.66M
P/E Ratio
5.4
Revenue Growth
0.0%
Analyst Upside
+127.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.43
|
$258.18M | - | 53 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.86
|
$256.54M | - | 61 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$9.07
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.92
|
$202.58M | - | 59 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.80
|
$188.81M | 326.3 | 53 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$7.05
|
$179.47M | - | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.83
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.01
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.30
|
$133.50M | - | 66 | Compare |
More CGEN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry